566: Policies to Curb Sexually Transmitted Infections, Xylazine Regulation and Testing

Dr. Anne Zink, ASTHO Immediate Past President and Chief Medical Officer for the Alaska Department of Health, says policies can help address the fact that the number of babies born with syphilis is ten times higher than in 2012; JoAnne McClure, ASTHO Senior Analyst for State Health Policy, outlines the different ways states and territories have reacted to xylazine being in the illicit drug supply; and Amani Echols, Policy and Government Affairs Manager for the Association of Maternal and Child Health Programs, discusses an online webinar revealing an article ASTHO worked on about public health approaches to perinatal substance use. ASTHO Webpage: Supporting a Syndemic Approach – Preventing Sexually Transmitted Infections ASTHO Blog Article: How the Emergence of Xylazine Impacts Overdose Prevention Policy ASTHO Webinar: Unveiling of the Perinatal Substance Use Special Issue in the Maternal and Child Health Journal Association of Maternal and Child Health Programs News Release: AMCHP and ASTHO Release Maternal and Child Health Journal Special Issue: Public Health Approaches to Perinatal Substance Use